<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04204590</url>
  </required_header>
  <id_info>
    <org_study_id>Z2018001</org_study_id>
    <nct_id>NCT04204590</nct_id>
  </id_info>
  <brief_title>Feasibility Study of a Systematic Approach for Deprescribing of Statins and PPI's.</brief_title>
  <acronym>FeDeS+P</acronym>
  <official_title>Feasibility Study of a Systematic Approach for Deprescribing of Statins and Proton Pump Inhibitors in Nursing Home Residents</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zuyderland Medisch Centrum</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zuyderland Medisch Centrum</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Deprescribing, the process of safely reducing or discontinuing unnecessary or harmful
      medication, has the potential to decrease polypharmacy and improve health outcomes. In this
      study a structured implicit algorithm, focusing on both extrinsic medication factors (eg
      change in disease) and intrinsic patient factors (eg. pill burden) will be used.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2, 2018</start_date>
  <completion_date type="Actual">July 3, 2019</completion_date>
  <primary_completion_date type="Actual">July 3, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>A multicentre, unblinded, single group (pre-comparison and post-comparison) feasibility study.</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Decrease in pill burden (the number of statins and PPI's)</measure>
    <time_frame>3 and 6 months after intervention.</time_frame>
    <description>On T0 (intervention) and on T1 + T2 (3 and 6 months after intervention), we will measure the number of PPI's and statins on the medication list of every participant. These are provided by the pharmacist.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Decrease in pill burden (the dose of statins and PPI's)</measure>
    <time_frame>3 and 6 months after intervention.</time_frame>
    <description>On T0 (intervention) and on T1 + T2 (3 and 6 months after intervention), we will measure the dose of PPI's and statins on the medication list of every participant. These are provided by the pharmacist.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>All possible negative side effects of deprescribing (e.g. nausea, symptom recurrence)</measure>
    <time_frame>From intervention to six months after intervention</time_frame>
    <description>All possible negative effects of deprescribing as recognised by the doctor involved, e.g. symptom recurrence.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Feasibility to use this algorithm.</measure>
    <time_frame>3 and 6 months after intervention</time_frame>
    <description>Three and six months after intervention we will ask the participating doctors the next questions (per included participant):
What did the algorithm advice you?
Did you follow the advice?
Why dit you follow/deny the advice?</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">75</enrollment>
  <condition>Polypharmacy</condition>
  <arm_group>
    <arm_group_label>Participants</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The aim of this study is to test the feasibility of this algorithm as an intervention to carry out deprescribing a targeted medication group, proton pump inhibitors (PPI's) and statins, among nursing home residents.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Deprescribing algorithm</intervention_name>
    <description>For this study an implicit, evidence-supported and patient-centred algorithm has been developed. The outcome of the algorithm is an advice to the doctor to deprescribe or not deprescribe the statin and/or PPI.</description>
    <arm_group_label>Participants</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participant uses a statin and/or a proton pump inhibitor.

          -  Participant signs informed consent.

          -  Participant is a nursing home resident.

        Exclusion Criteria:

          -  Participant is there for short term nursing home admission (&lt;3 months)

          -  Participant is there for hospice admission.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jos Schols, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Principal Investigator</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Lemborgh</name>
      <address>
        <city>Sittard</city>
        <state>Limburg</state>
        <zip>6135CV</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <link>
    <url>http://www.verensotijdschrift.nl/om2018/februari-2018/actueel/anne-visser-winnares-tvo-pen-2017/#.Wt3rza9lKvs</url>
    <description>Deprescribing algorithm</description>
  </link>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>May 1, 2018</study_first_submitted>
  <study_first_submitted_qc>December 16, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 19, 2019</study_first_posted>
  <last_update_submitted>December 16, 2019</last_update_submitted>
  <last_update_submitted_qc>December 16, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Deprescribing</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

